Table 2.

Univariable associations of categorical variables and MICRA scores

	Distress		Uncertainty		Total
	Mean (SD)	p-value	Mean (SD)	p-value	Mean (SD)	p-value
Partnered		0.84		0.24		0.37
Yes	6.0 (6.8)		12.0 (9.6)		25.0 (16.3)
No	5.6 (6.4)		14.8 (7.9)		28.7 (15.8)
Children		0.10		0.006		0.02
Yes	7.4 (7.2)		16.2 (8.6)		31.4 (16.3)
No	4.5 (6.1)		10.1 (8.5)		21.9 (15.0)
Post-secondary education		0.17		0.80		0.64
Yes	6.2 (7.0)		13.0 (9.1)		26.9 (16.6)
No	3.8 (4.3)		13.8 (8.7)		24.3 (13.7)
Household income		0.40		0.09		0.29
<  75, 000 CAD	7.9 (7.5)		17.0 (10.0)		32.4 (18.0)
≥ 75, 000 CAD	6.0 (6.5)		11.9 (8.6)		26.6 (16.5)
Race/Ethnicity		0.75		0.37		0.70
White	6.1 (7.0)		12.5 (8.3)		26.1 (16.0)
Other	5.4 (6.1)		14.9 (10.2)		27.9 (15.1)
Cancer stage		0.89		0.73		0.71
I/II	6.8 (7.3)		14.3 (8.3)		28.8 (15.3)
III/IV	5.9 (6.8)		13.1 (9.2)		26.6 (16.6)
Tumour results		0.23		0.16		0.10
Positive	7.7 (7.7)		15.6 (9.1)		31.9 (17.4)
Negative	5.3 (6.3)		12.2 (8.9)		24.6 (15.4)
Primary treatment		0.002		0.009		0.02
Neoadjuvant chemotherapy	3.0 (4.8)		9.6 (7.5)		21.1 (12.8)
Surgery	7.9 (7.2)		15.6 (9.2)		30.4 (17.4)
Personal history breast cancer		0.004		0.63		0.35
Yes	2.0 (2.0)		11.3 (8.1)		20.3 (9.8)
No	6.4 (6.9)		13.5 (9.1)		27.5 (16.7)
Family history breast/ovarian cancer		0.13		0.46		0.17
Yes	7.4 (7.5)		14.2 (9.4)		29.9 (17.9)
No	4.8 (5.9)		12.5 (8.7)		24.2 (14.4)
Previous genetic testing in family		0.77		0.91		0.81
Yes	6.7 (7.3)		13.7 (9.5)		28.3 (17.7)
No	6.0 (6.8)		13.4 (9.0)		27.0 (16.1)
Genetic counselling prior to survey		0.45		0.56		0.21
Yes	5.3 (6.9)		12.5 (9.2)		24.0 (15.6)
No	6.6 (6.7)		13.9 (8.9)		29.2 (16.7)

Univariable results from the subset of participants who completed the MICRA questionnaire (n = 63)